Continuum Advisory’s Inspire Corporate Bond ETF IBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-1,280
Closed -$30.4K 932
2025
Q1
$30.4K Hold
1,280
﹤0.01% 781
2024
Q4
$30K Buy
1,280
+939
+275% +$22.3K ﹤0.01% 765
2024
Q3
$8.07K Hold
341
﹤0.01% 1056
2024
Q2
$7.95K Hold
341
﹤0.01% 1004
2024
Q1
$7.95K Buy
+341
New +$8.02K ﹤0.01% 998

Other funds holding IBD

Continuum Advisory's IBD Position: Q2 2025 in Review

Continuum Advisory sold out of Inspire Corporate Bond ETF (IBD) in Q2 2025, closing a stake of 1,280 shares — an estimated $30.4K sold.

Continuum Advisory first reported a position in IBD in Q1 2024 and held it in 5 quarters. The position peaked at $30.4K in Q1 2025. 94 funds tracked by Wall St. Rank hold IBD as of Q2 2025.

  • Continuum Advisory reported no remaining Inspire Corporate Bond ETF position as of Q2 2025 after selling out during the quarter.
  • Continuum Advisory sold 1,280 Inspire Corporate Bond ETF shares in Q2 2025, an estimated $30.4K.
  • Continuum Advisory first reported a position in Inspire Corporate Bond ETF in Q1 2024 and held it in 5 quarters.
  • Continuum Advisory's Inspire Corporate Bond ETF position peaked at $30.4K in Q1 2025.
  • 94 funds tracked by Wall St. Rank held Inspire Corporate Bond ETF as of Q2 2025.

Based on Continuum Advisory's 13F filing for Q2 2025, filed 13 Aug 2025.